Pharmafile Logo
Pharmafocus logo
Advanced Search

Eylea HD

Showing 1 posts of 1 posts found.

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026
Research and Development Eylea HD, Opthalmology, Regeneron

Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026